Get it on Google Play

Sputnik V Vaccine : Approved For Emergency Use In India

Sputnik V:

Russia’s COVID-19 vaccine — Sputnik V — has been recommended for emergency use authorization in India following a meeting of the Subject Expert Committee (SEC).

  • If approved by the Drug Controller General of India (DCGI), Sputnik V would be the third vaccine to be made available in India after the Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.
  • Sputnik V, developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, claims to be one of the three vaccines in the world with an efficacy of over 90%.
  • the vaccine supplies for the global market will be produced by the Russian Direct Investment Fund (RDIF) international partners in India, Brazil, China, South Korea, and other countries.
Get it on Google Play

Leave a Reply

Your email address will not be published. Required fields are marked *